Upneeq is a prescription eye drop that lifts droopy upper eyelids by activating a small muscle inside the eyelid itself. The active ingredient, oxymetazoline 0.1%, targets receptors on a muscle called the Muller’s muscle, causing it to contract and pull the eyelid upward. The effect starts within 5 minutes of putting in the drop, and clinical trials measured significant lid elevation lasting through at least 6 hours.
The Muscle Behind the Lift
Your upper eyelid has two muscles responsible for keeping it open. The larger one does most of the heavy lifting. But there’s a smaller, thinner muscle called Muller’s muscle that provides a few extra millimeters of lift, fine-tuning your eyelid position. Muller’s muscle is controlled by your sympathetic nervous system (the same “fight or flight” system that dilates your pupils when you’re startled), and it responds to a type of chemical signal called alpha-adrenergic stimulation.
Upneeq delivers oxymetazoline directly to the surface of the eye, where it reaches Muller’s muscle and activates those alpha-adrenergic receptors. This makes the muscle contract, pulling the upper eyelid higher. You may recognize oxymetazoline as the same compound in nasal decongestant sprays, where it shrinks swollen blood vessels. In Upneeq, the concentration is much lower (0.1%) and formulated specifically for the eye.
How Fast It Works and How Long It Lasts
In Phase 3 clinical trials, measurable eyelid lift appeared within 5 minutes of instilling the drop. At 5 minutes on day one, patients using Upneeq gained an average of about 0.6 mm of lift, compared to 0.2 mm with placebo drops. By 15 minutes, that increased to roughly 0.9 mm. While a millimeter may sound small, in the context of an eyelid partially blocking your vision or making your eyes look asymmetrical, it’s a noticeable change.
The lift remained significant at the 2-hour and 6-hour marks, which were the latest time points measured in the trials. Most users report the effect lasting roughly 6 to 8 hours, covering a full day of activity. Since it’s a once-daily drop, the effect gradually wears off by evening. Importantly, the trials showed consistent performance across 42 days of daily use, with the 5-minute lift remaining statistically significant on days 1, 14, and 42. There was no evidence of the effect diminishing over that period.
What Upneeq Treats (and Doesn’t)
Upneeq is FDA-approved specifically for acquired ptosis, which is eyelid drooping that develops over time rather than being present from birth. The most common cause is age-related stretching or weakening of the muscles and tendons that hold the eyelid up. This affects a surprisingly large number of adults, particularly after age 40.
Because Upneeq works by stimulating Muller’s muscle, it’s most effective when that muscle is still intact and functional. It’s not designed for congenital ptosis (drooping present since birth), where the muscle structure itself may be underdeveloped. It also won’t help with mechanical ptosis caused by a physical mass or significant excess skin weighing the eyelid down. For severe ptosis where the eyelid droops far enough to block the pupil, surgery is typically the more effective option.
How to Use It
The dosing is straightforward: one drop in the affected eye (or both eyes, if needed) once per day. Each dose comes in a single-use vial that contains enough solution for both eyes. You open the vial, instill the drop, and discard the container immediately, even if liquid remains. Don’t let the tip of the vial touch your eye or any other surface.
If you wear contact lenses, remove them before putting in the drop and wait at least 15 minutes before reinserting them. If you use other eye drops, space them at least 15 minutes apart from Upneeq.
Common Side Effects
In clinical trials involving 375 patients using Upneeq, side effects were generally mild. The most frequently reported were:
- Punctate keratitis (tiny scratches on the cornea surface): 4% of patients
- Eye redness: 3%
- Dry eye: 2%
- Blurred vision: 2%
- Pain at the instillation site: 2%
- Headache: 2%
Overall, about 20% of patients on Upneeq reported some type of eye-related side effect, compared to 14% of those using placebo drops. Most of these were transient and didn’t lead people to stop treatment. Eye irritation occurred in about 1% of users.
Drug Interactions and Cautions
Upneeq has no absolute contraindications listed in its prescribing information, but there are important precautions. Because alpha-adrenergic stimulation can affect blood pressure, Upneeq should be used cautiously if you have severe or unstable heart disease, uncontrolled high or low blood pressure, or poor blood flow to the brain or heart.
Several types of medications warrant extra caution when combined with Upneeq. Beta-blockers, blood pressure medications, and cardiac glycosides can interact because they also influence cardiovascular function. Alpha-blocker medications, sometimes prescribed for high blood pressure or enlarged prostate, may work against Upneeq’s mechanism. MAO inhibitors, a class of antidepressant, can affect how the body processes the active ingredient.
People with untreated narrow-angle glaucoma should also be cautious, as Upneeq may increase the risk of an angle closure episode. Those with Sjögren’s syndrome, a condition that causes severe dry eyes and mouth, may find their symptoms worsen.
What Upneeq Won’t Do
Upneeq is a daily maintenance treatment, not a permanent fix. The lift it provides is temporary and returns to baseline once the drug wears off. It also can’t replace surgery for people with severe ptosis or excess eyelid skin (dermatochalasis), where the problem is structural rather than muscular. Some people use Upneeq as a bridge while deciding about surgery, or as a long-term alternative if surgery isn’t appealing or appropriate. The drop treats the symptom of drooping, not the underlying cause of muscle or tendon weakening, so stopping the medication means the droop returns.